In Botox® and facial injectables, technique gets most of the attention. The brand choice, the depth, the dosage — these are the things we talk about.
But there’s a step that happens before and after your needle is ever in hand — one that is just as critical to patient results, compliance, and your practice’s legal standing — and it’s still being overlooked far too often.
That step is documentation.
And the consequences of getting it wrong aren’t hypothetical. A review of 1,185 dental malpractice claims found that documentation issues appeared in nearly one in five of them — ranking as the fifth-leading cause across all dental specialties. Not bad injections. Not missed diagnoses. Inadequate records.
If that feels distant from your Botox chair, it shouldn’t. The mechanism is identical: when your records are incomplete, they stop being your defence — and start becoming the opposing argument.
Marking your Botox® patient’s injection sites: a clinical tool, not a formality
Placing anatomical injection site markings on your patient prior to treatment is more than a preparation step — it’s a clinical decision-making tool.
When you mark out your treatment plan on your patient’s face before you begin, you’re anchoring your intent. You’re committing to a plan based on assessment, anatomy, and patient goals — not reacting in real time. That level of intentionality translates directly into more precise, consistent results.
It also protects you. If a complication arises or a patient questions a result, your pre-treatment markings tell a story about your clinical reasoning and your process. They demonstrate that the treatment was planned, not improvised.
Landmarking, or placing injection site markings, is good practice. But what happens to those markings after the treatment ends is where many injectors fall short.
The double gap in our industry
There are two gaps in how injectors currently approach documentation — and both are worth examining honestly.
Gap One: Injectors who aren’t marking at all.
This is still happening. No pre-treatment mapping, no documented plan — just freehand injection based on experience and memory. Beyond the clinical risks this presents, it creates real exposure from a compliance and legal standpoint. In the absence of proper documentation, there is no evidence of informed, structured practice.
Gap Two: Injectors who are marking — but not capturing those markings properly.
This is the gap that doesn’t get talked about enough. The markings go on. The treatment happens. Then the patient is cleaned up, and the markings are gone. There’s no photograph. Nothing in the patient file that reflects the exact treatment plan – what was actually done and where.
In both cases, the practitioner is left without a reliable clinical record — and that gap becomes a problem the moment a patient walks back into your practice.
What weak Botox® records actually cost you
This isn’t a theoretical risk. CDSPI, the dental profession’s primary malpractice insurer in Canada, is explicit: when records contain lapses, errors, or inconsistencies, a patient’s counsel will use them to draw negative inferences about the quality of your care. The record becomes the evidence. If it’s incomplete, it becomes the case against you.
The data from broader medicine is equally sobering. An analysis of more than 65,000 malpractice cases found that documentation problems more than double the odds of a claim closing with an indemnity payment. The specialty is different. The mechanism is not.
You may have done everything right at the chair. But if your record doesn’t show it, that may not matter.
The follow-up problem: what system do you have in place?
Here’s a scenario every injector knows:
A patient returns at their two-week follow-up. The results aren’t quite right. Maybe the forehead still has movement it shouldn’t. The brows are uneven. Or you’re dealing with a droop.
Now the question is: what exactly did you do?
What was the precise location of each injection site? How many units at each point? Without a clear visual record, you’re reconstructing a treatment from memory — and making clinical decisions based on guesswork. That’s not just a clinical problem. It’s a liability problem.
Memory is not a medical record. And in a complaint scenario, it won’t be treated as one.
Why proper documentation matters: compliance, legal and clinical
When Botox® injection site markings are properly photographed and filed as part of the patient record, you gain:
- A legal record that demonstrates planned, informed treatment and protects your practice in the event of a complaint or adverse result.
- A compliance foundation that reflects best-practice standards and supports your professional accountability.
- A clinical assessment tool for follow-up appointments, case assessment and treatment refinement.
- Continuity of care that is particularly critical if the patient is ever seen by a different injector, or if you’re reviewing a case months later.
- A foundation for case assessment that allows you to compare before, during, and after — and build genuine clinical insight over time.
Raising the standard: what best-in-class Botox® documentation actually looks like
The Botox® injectors who are elevating the standard of care in our field aren’t just technically skilled. They’re building systems around their practice.
Good documentation isn’t photos sitting in a camera roll, or markings that disappear the moment you wipe the skin. It’s a structured workflow that ties together your pre-treatment landmarking, injection details, and photographic records into something you can actually retrieve and use at follow-up.
If you’re marking but not photographing those injection sites — you’re halfway there. If you’re not marking at all — it’s time to start. And if you’re doing both, but without a consistent system that makes that data retrievable and meaningful — there’s still work to be done.
The conversation our industry needs to have isn’t just about whether to document. It’s about what happens when you don’t — and whether your current workflow would hold up if it needed to.
Do you have that workflow in place? If not — that’s the next step. Contact us to learn more.
Carly Olynyk, Founder & CEO